Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
KOS-862
DRUG
2 trials
Sponsors
Bristol-Myers Squibb
Conditions
Lung Cancer
Prostate Cancer
Phase 2
Effectiveness of KOS-862 in the Treatment of Lung Cancer
Terminated
NCT00080509
Bristol-Myers Squibb
Lung Cancer
Start: 2003-12-31
End: 2004-11-30
Target: 85
Updated: 2010-02-03
Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer
Terminated
NCT00104130
Bristol-Myers Squibb
Prostate Cancer
Start: 2004-12-31
End: 2005-02-28
Target: 53
Updated: 2008-09-17